SARS-CoV

CAS No.	Product Name	Inquiry
2367587-02-6	Viral polymerase-IN-1 hydrochloride
2377482-36-3	Plonmarlimab
2382896-07-1	Sibeprenlimab
2409178-86-3	SARS-3CLpro-IN-1 SARS 3CLpro-IN-1 (Compound 3b) is a SARS 3CL protease inhibitor with an IC50 value of 95 μM, as a specific stereo isomer of the octahydroisochromene scaffold, directs the P1 site imidazole.
2410075-64-6	CTSL/CAPN1-IN-2
2412965-59-2	SARS-CoV-2-IN-1
2413716-71-7	SARS-CoV MPro-IN-1 SARS-CoV MPro-IN-1 is an inhibitor of SARS coronavirus main proteinase and inhibits SARS-CoV-2 replication in cell culture.
2415933-40-1	Imdevimab
2415933-42-3	Casirivimab
2417283-44-2	MI-1851 MI-1851 is a potent furin inhibitor. MI-1851 prevents the proteolytic processing of the S protein of SARS-CoV-2 by endogenous flavoprotease in HEK293 cells. MI-185 has antiviral activity.
2420563-99-9	Cilgavimab
2420564-02-7	Tixagevimab
2423014-07-5	Sotrovimab
2423016-74-2	Beludavimab
2423943-37-5	Bamlanivimab Bamlanivimab is a monoclonal antibody granted Emergency Use Authorization (EUA) in November 2020 by FDA for COVID-19 therapy. Bamlanivimab is directed against the spike protein of SARS-CoV-2, designed to block the virus' attachment and entry into human cells.
2423948-94-9	Etesevimab Etesevimab is a human recombinant monoclonal antibody that targets the SARS-CoV-2 surface spike protein receptor-binding domain. Etesevimab has been authorized for emergency use by the FDA for the treatment of COVID-19.
2432956-06-2	3CPLro-IN-1 3CPLro-IN-1 is a potent and orally active inhibitor of SARS-CoV-2 3CLpro with an IC50 of 5.65 μM. 3-Chymotrypsin-like cysteine protease (3CLpro) is an indispensable protein in viral replication and represents an attractive drug target for fighting COVID-19.
24394-09-0	Cnicin
244285-12-9	Hispidulin 4'-O-glucoside Hispidulin 4'-O-β-D-glucopyranoside is found in Abrus precatorius.
2444308-95-4	Regdanvimab

※ Please kindly note that our services are for research use only.